Navigation Links
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
Date:7/31/2008

2,350.0 1,382.1 2,737.0

________ _______ ________ ________

Operating (loss)/income (67.3) (1,775.1) 95.7 (1,633.9)

Interest income 6.5 14.9 19.2 34.7

Interest expense (16.8) (28.0) (34.1) (35.8)

Other income/(expenses), net 0.7 1.8 13.4 2.3

________ _______ ________ ________

Total other (expenses)/income, net (9.6) (11.3) (1.5) 1.2

________ _______ ________ ________

(Loss)/income before income taxes

and equity in (losses)/earnings of

equity method investees (76.9) (1,786.4) 94.2 (1,632.7)

Income taxes (0.2) (25.6) (44.3) (67.1)

Equity in (losses)/earnings of

equity method investees (1.9) 0.7 (0.3) 1.2

________ _______ ________ ________

Net (loss)/income (79.0) (1,811.3) 49.6 (1,698.6)

________ _______ ________ ________

(1) For the three months to June 30, 2007 $4.7 million of depreciation

was reclassified from Selling, general and administrative (SG&A)

costs to Cost of product sales ($1.9 million) and Research and

Development costs ($2.8 million). For the six months to June 30, 2007

$8.7 million of depreciation was reclassified from SG&A costs to Cost

of product sales ($3.9 million) and Research and development ($4.8

million).

(2 ) Cost of product sales includes amortization of intangible assets

relating to favorable manufacturing contracts of $0.4 million for

the three months to June 30, 2008 (2007: $nil) and $0.9 million for

the six
'/>"/>

SOURCE Shire Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. Shire Engages Palio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ons and recognized refractive and cataract surgery...ught their fellow surgeons up-to-date on the lates...act surgery, and ophthalmology in general at the r...y (AAO) annual meeting in San Francisco, Californi...David Huang, MD, Dr. Randy Epstein, Dr. William Tr...
(Date:11/19/2009)...red by latest award for revolutionary hearing aid....ember 16, 2009 -- Popular Science Magazine has nam...rom InSound Medical a winner of its coveted Best o...bsp;   Chosen from thousands of ent...ring canal for up to four months while providing n...
(Date:11/18/2009)...ire/ -- Marrone Bio Innovations (MBI), a leader in...of effective and environmentally responsible pest ...med an IC20 company by the Investors, Circle, the ...nvesting group. ,, Companies named to the IC20 ...for all stakeholders, including investors, the env...
(Date:11/18/2009)...to find explosive materials and persons who have b...e National Institute of Standards and Technology (...d Security, has developed a new certified referenc..., Trace Particulate Explosives. Compatible with fi...helpful in calibrating, testing and developing sta...
Breaking Biology Technology:Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Marrone Bio Innovations Named an IC20 Company 2New NIST trace explosives standard slated for homeland security duty 2
..., March 10 VIASPACE Inc. (OTC Bulletin Board: V... and Trademark Office issued patent number 7, 499,...rs detection and measurement of water vapor (humid...eams from combustion processes such as automobiles...rvitz and VIASPACE CEO Dr. Carl Kukkonen. , , VIA...
...s of DVT to Mark U.S. House of Representatives Nat...ition to Prevent DVT today announced the launch of...ss about deep-vein thrombosis (DVT) and to encoura...atients about this serious but preventable conditi...hospitals and local communities nationwide during ...
... Tolerx, Inc., today announced that DEFEND ( D ur...r N ew Onset Type 1 D iabetes), the Phase 3 tria...ed immunotherapeutic, has begun enrollment of new ...e. In DEFEND, preserving beta cell function subse... primary outcome that is being evaluated. This ou...
Other Biology Technology:VIASPACE Granted US Patent 2The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment 2The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment 3The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment 4The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment 5Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe 2Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe 3Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe 4
(Date:11/19/2009)... years ago, at the end of the last ice age, North ...ing such iconic creatures as mammoths, mastodons, ...egan their precipitous slide to extinction. , An...whose diversity of large animals equaled or surpas...r now, an entirely novel ecosystem emerged as broa...
(Date:11/19/2009)...entists are revealing the genetic instructions ins... or maize, has one of the most complex sequences o...Madison genomicist David Schwartz, who was one of ...l Science . , "The maize genome is a true maze ... troubled would-be sequencers for years," says Sch...
(Date:11/19/2009)...1 + 1 = more than 2: The offspring of two inbred s...s. Characterizing the gene-level variability that ...brid vigor, could boost our ability to custom-tail... content for human consumption or high glucose con...ly released DNA sequence of the common corn strain...
Breaking Biology News(10 mins):After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2Black gay men may be at increased HIV risk 50292 1Black gay men may be at increased HIV risk 50292 2Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 1Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 2Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 3Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 4Working to conserve endangered Playboy bunnies 9046 1Working to conserve endangered Playboy bunnies 9046 2
...very of how some abnormal cells can avoid a bioche...eir energy level and repairing the damage, is givi...ospital insights into a key strategy cancer cells ... explanation of how abnormal cells that have cheat...y called apoptosis can also foil a backup self-des...
...est that detects proteins commonly released by a g...r monitoring the effectiveness of chemotherapy and...t cancer, according to a study published in the Ju...cientists in the National Institute on Deafness an...al Cancer Institute (NCI), two of the National Ins...
...archers have hypothesized that the fetus can be ex...rgens to which the mother has been exposed, and th...ic sensitivity (e.g. eczema and asthma) later in a...ned controversial because of an inability to detec..., a newly developed technique known as MHC tetrame...
Other Biology News:Cells re-energize to come back from the brink of death 2Blood test may help signal tumor's remission, return in throat cancer patients 2Blood test may help signal tumor's remission, return in throat cancer patients 3Blood test may help signal tumor's remission, return in throat cancer patients 4
Caspase-3/7 Inhibitor I from Calbiochem
Mouse Anti-Cig2 Monoclonal Antibody, Unconjugated, Clone CIG 3A11 / 5 from Abcam
Rabbit Anti-CAMK 1D beta Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human HNF4 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: